To improve lives, mobility and independence from neurodegenerative disease with human inspired medicine design.
Talon Pharmaceuticals was founded in 2012 and is focused on the discovery and development of small molecule drugs for neurodegenerative disorders. Talon is building a portfolio of single drugs and combinations that target more than one mechanism of action (multi-action drugs). We are delivering the next generation of small molecule therapeutics for improving the quality of life of patients living with Parkinson’s disease. We utilize translational and knowledge/structure-based approaches to advance purpose-built medicines for the treatment of symptoms and disease progression.
Our team has extensive drug discovery, development and clinical expertise in advancing drugs for central nervous system disorders.